The SIMBIΩ technology represents an innovation in the nutraceutical sector, designed to improve the paracellular uptake of active ingredients through the intestinal barrier, without causing issues related to various inflammatory syndromes.
This technology was developed with the goal of overcoming the challenges related to ingredient absorption, allowing them to pass more easily through membranes and subsequently reach the bloodstream, where they can effectively exert their benefits.
Unlock the real power of nutrients
The SIMBIΩ technology is based on the combination of two oils in a microemulsion which, through a specific process, is able to optimize the performance of the treated ingredient by improving intestinal absorption, without falling under the novel food issue.
The SIMBIΩ technology can be applied to both individual ingredients and blends, thus offering high flexibility and adaptability to the specific needs of clients. This customization capability allows for the creation of unique and highly effective formulations, tailored to meet the needs of a specific consumer target or particular health issues.
Another strength of the SIMBIΩ technology is its European patent status, confirming its uniqueness in the nutraceutical landscape. This demonstrates the company's commitment to promoting research and the development of advanced solutions for the improvement of formulations and products aimed at consumer health and well-being.
The SIMBIΩ technology enables the creation of nutraceutical products that stand out for their improved efficacy and reliability.
This is achieved thanks to the results obtained through pre-clinical studies on intestinal organoids, conducted using methodologies approved by the FDA and EMA, which ensure reliable, reproducible data that are consistent with those obtained from human clinical studies.